Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001013723 | SCV001174346 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002068875 | SCV002469944 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2020-11-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003425881 | SCV004139558 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | SMARCA4: PM2:Supporting, BP4, BP7 |